Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor coactivator 6 (NCOA6) is a large, multifunctional transcriptional coactivator protein that interacts with various nuclear hormone receptors (including steroid, thyroid, retinoid, and vitamin D receptors) to enhance their transcriptional activity[5][6][4]. NCOA6 also functions as a general transcriptional coactivator by associating with basal transcription factors and chromatin-modifying enzymes, such as histone acetyltransferases and methyltransferases, thereby influencing epigenetic regulation[3][4][5]. It is involved in a broad range of biological processes, including embryonic development, metabolism, cell proliferation, and the regulation of inflammation via participation in the activation of the NLRP3 inflammasome[1][3][7]. The gene encoding NCOA6 is often amplified and overexpressed in several cancer types, implicating it as an oncogenic driver or facilitator[3]. Multiple isoforms of NCOA6 exist due to alternative splicing, resulting in differential subcellular localization and functional diversity among tissues[7]. Knockouts in mice demonstrate that NCOA6 is essential for viability and the development of several organ systems[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor coactivator 6 (NCOA6).